Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.
Emery
P
P
Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds. p.emery@leeds.ac.uk [corrected]
Van Vollenhoven
R
R
Ostergaard
M
M
Choy
E
E
Combe
B
B
Graninger
W
W
Krueger
K
K
Matucci-Cerinic
M
M
Navarro
F
F
van Riel
P
P
Settas
L
L
Steinfeld
S
S
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005060:Europe; D006801:Humans; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha